AKT1 and acute respiratory distress syndrome: In this study, we further confirmed that ibrutinib has a significant therapeutic effect on poly I:C- and LPS- induced ALI mouse models by inhibiting the abnormally activated BTK/ERK- and BTK/AKT/NFκB-signaling pathways.